Min-ji Charng

TPQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Evolocumab in Patients With Prior Percutaneous Coronary Intervention and No Prior Myocardial Infarction: Results From the VESALIUS-CV Trial.

Evolocumab in Patients With Prior Percutaneous Coronary Intervention and No Prior Myocardial Infarction: Results From the VESALIUS-CV Trial.

Journal: Circulation

Published: May 19, 2026

Evolocumab in Patients With Prior Percutaneous Coronary Intervention and No Prior MI: Results From the VESALIUS-CV Trial.

Evolocumab in Patients With Prior Percutaneous Coronary Intervention and No Prior MI: Results From the VESALIUS-CV Trial.

Journal: Circulation

Published: May 19, 2026

A nationwide genetic and phenotypic spectrum of 63 probands of homozygous familial hypercholesterolemia in Taiwan.

A nationwide genetic and phenotypic spectrum of 63 probands of homozygous familial hypercholesterolemia in Taiwan.

Journal: Journal of clinical lipidology

Published: December 08, 2025

Olezarsen for Managing Severe Hypertriglyceridemia and Pancreatitis Risk.

Olezarsen for Managing Severe Hypertriglyceridemia and Pancreatitis Risk.

Journal: The New England journal of medicine

Published: November 10, 2025

Correction to: Evinacumab for Pediatric Patients With Homozygous Familial Hypercholesterolemia.

Correction to: Evinacumab for Pediatric Patients With Homozygous Familial Hypercholesterolemia.

Journal: Circulation

Published: July 07, 2025

Unveiling hidden dangers: quantitative analysis of ischemic risks in high-risk patients with ASCVD and dyslipidemia.

Unveiling hidden dangers: quantitative analysis of ischemic risks in high-risk patients with ASCVD and dyslipidemia.

Journal: American journal of physiology. Heart and circulatory physiology

Published: January 29, 2025

Lower body mass index is associated with the achievement of target LDL in patients using PCSK9 inhibitors in Taiwan.

Lower body mass index is associated with the achievement of target LDL in patients using PCSK9 inhibitors in Taiwan.

Journal: European journal of medical research

Published: December 27, 2024

Implementing Sustainable Practices in the Cardiac Catheterization Laboratory: Results from a Year-Long Waste Reduction Initiative.

Implementing Sustainable Practices in the Cardiac Catheterization Laboratory: Results from a Year-Long Waste Reduction Initiative.

Journal: Acta Cardiologica Sinica

Published: December 10, 2024

The analysis of the breakpoint of large rearrangements of LDLR gene in a Taiwanese cohort of patients with familial hypercholesterolemia.

The analysis of the breakpoint of large rearrangements of LDLR gene in a Taiwanese cohort of patients with familial hypercholesterolemia.

Journal: Journal of clinical lipidology

Published: November 24, 2024

Safety and Efficacy of BioMime Sirolimus-Eluting Stent System in All-Comers Real-World Population With Coronary Artery Stenosis: MILES Global Registry.

Safety and Efficacy of BioMime Sirolimus-Eluting Stent System in All-Comers Real-World Population With Coronary Artery Stenosis: MILES Global Registry.

Journal: Cardiology research

Published: September 02, 2024

Evinacumab for Pediatric Patients With Homozygous Familial Hypercholesterolemia.

Evinacumab for Pediatric Patients With Homozygous Familial Hypercholesterolemia.

Journal: Circulation

Published: October 20, 2023

Sex and age differences of major cardiovascular events in patients after percutaneous coronary intervention.

Sex and age differences of major cardiovascular events in patients after percutaneous coronary intervention.

Journal: Journal of the Chinese Medical Association : JCMA

Published: October 10, 2023

Showing 1-12 of 41

Last Updated: 09/26/2026